Business
Tetra Bio Pharma Announces Filing of Final Base Shelf Prospectus for up to $50 Million of Securities
Tetra Bio Pharma Announces Filing of Final Base Shelf Prospectus for up to $50 Million of Securities.
About this update from Tetra Bio-pharma Inc.
[{"type":"text","content":"\n\n\n\nTetra Bio Pharma Announces Filing of Final Base Shelf Prospectus for up to $50 Million of Securities\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nTetra Bio Pharma Announces Filing of Final Base Shelf Prospectus for up to $50 Million of Securities\nCanada NewsWire\nOTTAWA, April 1, 2020\n\n\n\n/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES/\n OTTAWA, April 1, 2020 /CNW Telbec/ - Tetra Bio-Pharma Inc. (\"Tetra\" or the \"Corporation\") (TSXV: TBP) (OTCQB: TBPMF) announced today that it has filed a final short form base shelf prospectus with the securities commissions in each of the provinces of Canada.\nThe base shelf prospectus will allow Tetra and certain of its security holders to qualify the distribution by way of prospectus of up to $50,000,000 of common shares, warrants, units, debt securities, subscription receipts, or any combination thereof, from time to time during the 25-month period that the shelf prospectus is effective. The specific terms of any future offering, and the intended use of the net proceeds resulting from such offering, will be established in a prospectus supplement to the shelf prospectus, which supplement will be filed with the applicable Canadian securities regulatory authorities in connection with any such offering. The nature, size and timing of any such offerings (if any) will depend, in part, on Tetra's assessment of its requirements for funding and general market conditions.\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, state or jurisdiction.\nA copy of the final short form base shelf prospectus can be found on SEDAR at www.sedar.com. \nAbout Tetra Bio-PharmaTetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery ...